Inhibitor combinations targeting KRAS effector signaling in KRAS-mutant pancreatic cancer

被引：1
作者：
Cox, Adrienne D. [1 ]
Goodwin, Craig M. [1 ]
Bryant, Kirsten L. [1 ]
Dagliyan, Irem [1 ]
George, Samuel D. [1 ]
Lucas, Kelly E. [1 ]
Gautam, Prson [2 ]
Wennerberg, Krister [2 ]
Der, Channing J. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] Inst Mol Med Finland, Helsinki, Finland
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-SY20-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY20-02
引用
收藏
页数：1
相关论文
共 50 条
[21]   Targeting KRAS-Mutant Non-Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib [J].
Acquaviva, Jaime ;
Smith, Donald L. ;
Sang, Jim ;
Friedland, Julie C. ;
He, Suqin ;
Sequeira, Manuel ;
Zhang, Chaohua ;
Wada, Yumiko ;
Proia, David A. .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (12) :2633-2643
[22]   Gaudichaudion H inhibits KRAS-mutant pancreatic cancer cell growth through interfering PDES-KRAS interaction [J].
Li, Lingyu ;
Liu, Qingying ;
Shao, Yuyu ;
Wang, Shuo ;
Liu, Shuangyu ;
Wang, Xiaoning ;
Wang, Shuqi ;
Ren, Dongmei .
CHEMICO-BIOLOGICAL INTERACTIONS, 2025, 415
[23]   Evaluating a role for Rac1-PAK1 signaling in promoting the growth of KRAS-mutant pancreatic cancer [J].
Baker, Nicole M. ;
LoBello, Janine ;
Han, Haiyong ;
Yin, Holly ;
Yeh, Jen Jen ;
Der, Channing J. .
MOLECULAR CANCER RESEARCH, 2014, 12
[24]   DUAL CHECKPOINT ABROGATION IS SYNERGISTIC IN KRAS-MUTANT CANCER [J].
不详 .
CANCER DISCOVERY, 2015, 5 (09) :903-903
[25]   A combinatorial strategy for treating KRAS-mutant lung cancer [J].
Eusebio Manchado ;
Susann Weissmueller ;
John P. Morris ;
Chi-Chao Chen ;
Ramona Wullenkord ;
Amaia Lujambio ;
Elisa de Stanchina ;
John T. Poirier ;
Justin F. Gainor ;
Ryan B. Corcoran ;
Jeffrey A. Engelman ;
Charles M. Rudin ;
Neal Rosen ;
Scott W. Lowe .
Nature, 2016, 534 :647-651
[26]   A pan-KRAS degrader for the treatment of KRAS-mutant cancers [J].
Yang, Jie ;
Wang, Qiao-Li ;
Wang, Guan-Nan ;
Ye, Jia-Cong ;
Li, Zi-Qian ;
Wang, Jing-Yun ;
Liang, Zhao-Hui ;
Li, Shu-Xin ;
Sun, Cong ;
Liao, Wen-Ting ;
Gao, Yi-Jun ;
Wang, Jing ;
Mao, Yong ;
Yu, Chunjing ;
Feng, Guo-Kai ;
Zeng, Mu-Sheng .
CELL DISCOVERY, 2024, 10 (01)
[27]   Hope for targeted treatment of KRAS-mutant lung cancer [J].
Crisp, Alisa .
EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (02) :121-121
[28]   A combinatorial strategy for treating KRAS-mutant lung cancer [J].
Manchado, Eusebio ;
Weissmueller, Susann ;
Morris, John P. ;
Chen, Chi-Chao ;
Wullenkord, Ramona ;
Lujambio, Amaia ;
de Stanchina, Elisa ;
Poirier, John T. ;
Gainor, Justin F. ;
Corcoran, Ryan B. ;
Engelman, Jeffrey A. ;
Rudin, Charles M. ;
Rosen, Neal ;
Lowe, Scott W. .
NATURE, 2016, 534 (7609) :647-+
[29]   A pan-KRAS degrader for the treatment of KRAS-mutant cancers [J].
Zeng, Mu-Sheng ;
Yang, Jie ;
Wang, Qiao-Li Wang ;
Wang, Guan-Nan ;
Ye, Jia-Cong ;
Li, Zi-Qian ;
Wang, Jing-Yun ;
Liang, Zhao-Hui ;
Li, Shu-Xin ;
Sun, Cong ;
Liao, Wen-Ting ;
Gao, Yi-Jun ;
Wang, Jing ;
Mao, Yong ;
Yu, Chunjing ;
Feng, Guo-Kai .
CANCER RESEARCH, 2025, 85 (08)
[30]   Treating KRAS-Mutant Lung Cancer With Combination Agents [J].
Shumeyko, Emma P. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (04) :315-315
12345